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The intestinal mucosa plays a critical role in the host’s interactions with innocuous commen-
sal microbiota and invading pathogenic microorganisms. Intestinal epithelial cells (IECs) and
gut associated immune cells recognize the bacterial components via pattern-recognition
receptors (PRRs) and are responsible for maintaining tolerance to the large communities of
resident luminal bacteria while being also able to mount inflammatory responses against
pathogens. Toll-like receptors (TLRs) are a major class of PRRs that are present on IECs
and immune cells which are involved in the induction of both tolerance and inflammation.
A growing body of experimental and clinical evidence supports the therapeutic and preven-
tive application of probiotics for several gastrointestinal inflammatory disorders in which
TLRs exert a significant role. This review aims to summarize the current knowledge of the
beneficial effects of probiotic microorganisms with the capacity to modulate the immune
system (immunobiotics) in the regulation of intestinal inflammation in pigs, which are very
important as both livestock and human model. Especially we discuss the role of TLRs, their
signaling pathways, and their negative regulators in both the inflammatory intestinal injury
and the beneficial effects of immunobiotics in general, and Lactobacillus jensenii TL2937 in
particular.This review article emphasizes the cellular and molecular interactions of immuno-
biotics with IECs and immune cells through TLRs and their application for improving animal
and human health.
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INTRODUCTION
The mammalian gastrointestinal tract harbors trillions of benefi-
cial commensal bacteria, a population composed of at least 1,000–
5,000 species (1). Studies probing the composition and function
of the endogenous microbiota in the normal gastrointestinal tract
have greatly expanded our appreciation for an understanding of
how the microbiota shape mucosal immune responses, as well as
how commensal bacteria in the gastrointestinal tract regulate the
production of immunoregulatory, diet-dependent nutrients and
metabolites (2). In fact, recent studies have highlighted that alter-
ations in the composition of commensal bacterial populations are
linked to multiple metabolic and inflammatory diseases in humans
including but not limited to inflammatory bowel disease (IBD),
obesity, type 2 diabetes, atherosclerosis, allergy, and colon cancer.
Mammals have an evolutionary partnership with the micro-
biota that is critical for host defense. In the gastrointestinal tract,
part of the local immune response is aimed at maintaining a peace-
ful coexistence with the resident microbiota. Abundant experi-
mental and clinical data support the idea that commensals residing
in the gastrointestinal tract can calibrate both innate and adaptive
responses (3, 4). Unique groups of commensals as well as defined
metabolites of commensals also can have key roles in the control
of mucosal responses (4). Additionally, despite being contained
by the intestinal mucosa, the gut microbiota can also modulate
immune responses at distal sites in the steady-state and during
inflammation (5).
In recent years, the study of microbe-intestinal cell interactions
has unraveled several molecular mechanisms and cellular path-
ways, showing that these interactions play a crucial role in the
regulation of several immunological functions in the gut. More-
over, better understanding of the host-microbe interactions in the
gut has provided new opportunities for preventing and treating
a number of inflammatory disorders such as the use of specific
probiotic strains to beneficially modulate the intestinal immune
system. Probiotic bacteria that are able to modulate the immune
system (immunobiotics) are demonstrably beneficial for treating a
variety of mucosal disorders, including inflammatory diseases (6).
Weaning-associated intestinal inflammation occurs in various
animal species including the pig. Intensification of the pig industry
has brought increased risks of both clinical and sub-clinical enteric
disease. Piglets are vulnerable to potentially harmful microorgan-
isms such as Escherichia coli, Salmonella spp., and Clostridium
perfringens (7). Antibiotics have been applied widely in ani-
mal husbandry to prevent and treat the gastrointestinal infection
caused by pathogens (8). However, the promiscuous use of antibi-
otics has resulted not only in the emergence and spread of resistant
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bacteria in humans but also in animals (9). Early weaning of
piglets is often accompanied by a high susceptibility to diarrhea.
It has been established that this process is multi-factorial and that
post-weaning inflammation and malnutrition are major etiolog-
ical factors. Pigs coexist with a dense and diverse microbiota in
their gut. As observed in humans, the microbial colonization of
the porcine intestine begins at birth and follows a rapid succes-
sion during the neonatal and weaning period (10, 11). Following
the withdrawal of sow’s milk the young piglets are highly suscep-
tible to enteric diseases partly as a result of the altered balance
between developing beneficial microbiota and the establishment
of intestinal bacterial pathogens. In addition to the changes in
microbiota composition, the intestinal immune system of the
newborn piglet undergoes a rapid period of maturation, expan-
sion, and specialization that is not achieved before commercial
weaning (10, 11).
Various nutritional approaches for optimizing the weaning
transition and minimizing gut inflammation and enteric diseases
have been tested in the past decade. Among the novel dietary strate-
gies investigated that are focused on improving gut health in pigs,
prebiotics and probiotics are clear nutritional options. This review
aims to summarize the current knowledge of the beneficial effects
of probiotic microorganisms with the capacity to modulate the
immune system (immunobiotics) in the regulation of intestinal
inflammation in pigs. We discuss the role of toll-like receptors
(TLRs), their signaling pathways, and their negative regulators in
both the inflammatory intestinal injury and the beneficial effects
of immunobiotics in general, and Lactobacillus jensenii TL2937 in
particular. This review article emphasizes the cellular and molec-
ular interactions of immunobiotics with intestinal epithelial cells
(IECs) and immune cells through TLRs and their application for
improving animal health and also human’s because the pigs are
expected to be a better human model than rodents.
TLR4 SIGNALING PATHWAY AND INFLAMMATION IN THE
GUT
Toll-like receptor-4 is expressed by epithelial and immune cells and
might play a role in the intestinal mucosal host defense against
Gram-negative bacteria. However, since many body surfaces are
colonized by the physiological microflora, activation of epithelial
TLR4 must be tightly controlled to avoid unintended stimulation
and mucosal inflammation.
Upon recognition of its cognate ligand, TLR4 dimerizes and
initiates a signaling cascade that leads to the activation of a pro-
inflammatory response (Figure 1). Ligand binding can induce two
signaling pathways, the myeloid differentiation primary response
gene 88 (MyD88)-dependent and MyD88-independent pathways,
which induce the production of pro-inflammatory cytokines and
type I IFNs (12). These two distinct responses are mediated via the
selective use of adaptor molecules recruited to the TIR domains
of the TLRs after ligand recognition and binding. Four adaptor
molecules have been identified so far: MyD88, TIR-associated pro-
tein (TIRAP), TIR domain-containing adaptor protein-inducing
IFN-β (TRIF), and TRIF-related adaptor molecules (TRAM)
(13). MyD88 and TIRAP are responsible for the induction of
pro-inflammatory genes, and TRIF and TRAM induce IFNs. In
MyD88-dependent signaling, upon ligand recognition, MyD88
FIGURE 1 | Toll-like receptor-4 signaling pathway.
is recruited to and associates with the cytoplasmic domain of
the TLRs. Then IL-1R-associated kinase 4 (IRAK-4) and IRAK-
1 are recruited and activated by phosphorylation. Activated
IRAK-4 phosphorylates IRAK-1, which subsequently associates
with tumor necrosis factor receptor (TNFR)-associated factor 6
(TRAF6). TRAF6 activates transforming growth factor (TGF)-
activating kinase 1 (TAK1) (Figure 1). TAK1 phosphorylates
IKK-b and mitogen-activated protein kinase (MAPK) kinase 6
(MKK6), leading to degradation of I-κB and thereby leading to
the nuclear translocation of NF-κB, which results in the induction
of genes involved in inflammatory responses (Figure 1). Activation
of the MyD88-dependent pathway also results in the activation of
MAPKs such as p38 and JNK, which leads to the activation of
AP-1 (13). For the MyD88-independent signaling TLR4 activation
triggers the induction of a type I IFN response, leading to the
induction of IFN-α and IFN-inducible genes.
Various negative regulatory mechanisms have evolved to atten-
uate TLR signaling and maintain the immune balance. At least
six levels of negative regulation have been discovered so far (14,
15): (i) degradation of TLRs; (ii) down-regulation of transcription
of TLRs and related genes; (iii) post-transcriptional repression
by microRNAs (miRNAs); (iv) production of soluble TLRs func-
tioning as decoy receptors; (v) intracellular inhibitors and; (vi)
membrane-bound suppressors that inhibit TLR signaling path-
ways after TLR and ligand interactions have occurred. TLR sig-
naling pathways can be tightly regulated by transmembrane pro-
teins ST2, single immunoglobulin interleukin-1-related receptor
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(SIGIRR), and TNF-related apoptosis-inducing ligand receptor
(TRAILR). SIGIRR is an orphan receptor that does not induce
NF-κB activation. It interacts with IRAK and TRAF6 and inhibits
TLR signaling. In contrast, TRAILR suppresses NF-κB activation
at downstream TLR signaling events, perhaps by stabilizing IκB
and preventing its degradation (14) (Figure 1). Another impor-
tant negative regulatory mechanism for TLR signaling involves
the endogenous intracellular negative regulators such as sMyD88
(the short form of MyD88), interleukin-1 receptor-associated
kinase M (IRAK-M), suppressor of cytokine signaling 1, NOD2,
phosphatidylinositol 3-kinase, Toll interacting protein (TOLLIP),
and A20. The intracellular negative TLR regulators can act at
multiple levels. For example, IRAK-M can heterodimerize with
IRAK-1 or -2 and bind both MyD88 and TRAF6. Upon TLR-
TIR-ligand engagement and formation of the MyD88 adaptor
complex, IRAK-M is thought to bind MyD88/IRAK-4 and inhibit
IRAK-4 phosphorylation of IRAK-1. This prevents formation of
TRAF6/IRAK-1 complexes, which initiate IκB kinase and MAPK
signaling pathways (16) (Figure 1). Some intracellular regula-
tors are constitutively expressed to control TLR activation at a
physiological level, whereas others are up-regulated by TLR signal-
ing during infection to attenuate the TLR response in a negative
feedback loop. Therefore, regulation of TLR signaling pathways
constitutes a complex network.
Toll-like receptor signaling in IECs and immune cells has been
shown to be involved in three important mechanisms that are cru-
cial for maintaining a healthy epithelial barrier: (i) epithelial cell
proliferation and maintenance of tight junctions; (ii) expression of
antimicrobial factors; and (iii) modulation of immune responses
[reviewed in Ref. (15)]. In a healthy individual, intestinal colo-
nization stimulates these mechanisms that in turn contain the
microbiota within the intestinal lumen and neutralize MAMPs.
Moreover, these mechanisms protect the host from the systemic
translocation of bacteria or bacterial products and from the out-
burst of pro-inflammatory cascades in intestinal epithelial and
innate cells (17).
MODULATION OF INTESTINAL INFLAMMATION BY
COMMENSAL BACTERIA
Several studies have identified a role for pattern-recognition recep-
tors (PRRs) in mediating non-inflammatory immune responses to
the microbiota, challenging the paradigm that PRRs have evolved
solely to recognize and respond to pathogens. MyD88-deficient
mice are more susceptible to DSS-induced colitis, suggesting that
commensal bacteria may be directly recognized by TLRs under
steady-state conditions to mediate host-protective responses (18).
To corroborate this notion, depletion of gut bacteria with antibi-
otics results in increased susceptibility to DSS; remarkably, oral
feeding of lipopolysaccharide and lipoteichoic acid corrects this
predisposition to colitis, revealing that TLR ligands have bene-
ficial effects on the host (18). As DSS induces intestinal injury,
these findings suggest that TLR signaling by the microbiota leads
to maintenance of intestinal epithelial homeostasis in the absence
of enteric pathogens. The polysaccharide from Bacteroides fragilis
is a unique TLR2 ligand found in the human microbiome, which
orchestrates anti-inflammatory immune responses that amelio-
rate diseases mediated by the immune system. This polysaccharide
is ingested by intestinal DCs, which then stimulate responses of
Foxp3+ Treg cells (19). Interestingly, TLR2-deficient mice are
not protected by the polysaccharide against colitis (20). TLR2-
deficient DCs do not promote responses of Foxp3+ Treg cells
and production of IL-10, demonstrating that specific gut bacterial
molecules have evolved to promote benefits to the host via PRR
signaling in antigen presenting cells. Studies have also demon-
strated that commensal organisms may target and inhibit NF-κB
activation to suppress inflammation. By analyzing the composi-
tion of the intestinal microbiota of Crohn’s disease patients, Sokol
et al. (21) identified Faecalibacterium prausnitzii, which is greatly
reduced in Crohn’s disease patients, as an anti-inflammatory com-
mensal bacterium in the gut by showing that the supernatant of
F. prausnitzii inhibits NF-κB activation in a human IEC line and
suppresses the production of pro-inflammatory cytokines both
in vitro and in a mouse colitis model. However, the molecular
mechanism by which this process occurs was not elucidated. Sev-
eral studies have also highlighted the importance of TLR-MyD88
signaling among lymphocytes. In B cell–specific MyD88-deficient
mice, bacteria disseminate to systemic sites, such as liver or
lung, after DSS-induced damage of the colon, but not in epithe-
lial cell–specific or dendritic cell–specific MyD88-deficient mice
(22). Further, it has recently been appreciated that T cell subsets
express functional TLRs (23). Transfer of MyD88-deficient T cells
into RAG-deficient mice results in less intestinal inflammation
(24). Conversely, whereas TLR signaling by T cells was classically
thought to promote immunity, it now appears that this process can
restrain inflammatory responses. For example, treatment of CD4+
T cell subsets with a TLR4 agonist increases suppressive activity
and enhances protection from colitis (25). Therefore, TLRs rep-
resent a dynamic signaling system that triggers various immune
outcomes, and TLR signaling directly by adaptive immune cells
mediates reactions in the absence of innate immune cells.
A growing list of inhibitors for TLR signaling in the intesti-
nal mucosa, including IRAK-M, TOLLIP, SIGIRR, A20, and per-
oxisome proliferator-activated receptor-γ (PPARγ), ensure that
chronic inflammatory and potentially destructive TLR responses
to MAMPs do not occur (26). In this regard, IECs deficient in
SIGIRR are more susceptible to commensal-dependent intesti-
nal inflammation, indicating that the intrinsic expression of
SIGIRR by IECs regulates the communication between commen-
sal bacteria and the host immune system (27). Additionally, an
anti-inflammatory mechanism activated by commensal B. thetaio-
taomicron that attenuates pro-inflammatory cytokine expression
in IECs by promoting nuclear export of the NF-κB subunit RelA
through a PPARγ-dependent pathway has been reported (28). Fur-
thermore, the contact time between IECs and commensal bacteria
seems to be critical, as short-term stimulation with LPS leads to
activation of pro-inflammatory signaling cascades in IECs, includ-
ing phosphorylation of IRAK and MAPK and increased IL-8 secre-
tion, whereas prolonged incubation results in a state of hypore-
sponsiveness with minimal reaction by the IECs. Up-regulation of
inhibitory TOLLIP contribute to this hyporesponsiveness (29).
In addition to TLRs, other PRRs have been involved in the
anti-inflammatory effects of gut microbiota. The peptidoglycan
recognition protein (PGRP) family is involved in the regulation
of commensal microbiota in mice. Mice deficient in any one
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of the four PGRPs harbor a microbiota that promote increased
sensitivity to DSS-induced colitis (29). Indeed, germ-free mice
inoculated with stool from PGRP-deficient donor mice are more
sensitive to DSS-induced colitis compared to mice that received
stool from wild-type mice and exhibit greater mortality, weight
loss, and colitis scores. Thus, mammalian PGRPs are important
in shaping a homeostatic commensal microbiota and preventing
intestinal inflammation (29). It is probable that in the near future
studies will demonstrate that other PRRs are involved in the com-
plex bidirectional cross-talk between commensal gut bacteria and
the host.
MODULATION OF INTESTINAL INFLAMMATION BY
PROBIOTIC BACTERIA
Several studies have shown that immunobiotics can beneficially
modulate the PRRs-mediated inflammatory response in the gut
by modulating the functions of IECs and APCs (30, 31).
Probiotics inhibit excessive NF-κB-induced pro-inflammatory
cytokine production by IECs. Immunobiotics suppress TNF- or S.
typhimurium-induced IL-8 gene expression and secretion by IECs
in an NF-κB-dependent manner (32, 33). A study in Caco-2 cells
demonstrated that Lactobacillus rhamnosus GG counteracts the
enterotoxigenic Escherichia coli (ETEC)-induced up-regulation of
IL-1β and TNF-α and the down-regulation of TGF-β1 expression,
consequently blocking cytokine deregulation (30). In addition,
comparative studies between L. rhamnosus GG and Bifidobac-
terium animalis MB5 demonstrated that individual strains of pro-
biotics have a different impact on the inflammatory response trig-
gered in IECs (30). Others studies evaluating the effect of immuno-
biotic yeasts have shown that Saccharomyces cerevisiae CNCM
I-3856 decreases the expression of the pro-inflammatory media-
tors IL-6, IL-8, CCL20, CXCL2, and CXCL10 in porcine intestinal
epithelial IPI-2I cells cultured with F4+ ETEC (34). Moreover, the
CNCM I-3856 strain inhibits ETEC-induced expression of pro-
inflammatory cytokines and chemokine transcripts and proteins,
and this inhibition is associated with a decrease in ERK1/2 and
p38 MAPK phosphorylation and an increase in the mRNA level
of anti-inflammatory PPARγ (35).
Additionally, the importance of direct stimulation of DCs by
immunobiotics to promote tolerance was illustrated by some
studies. Comparative studies using Lactobacillus plantarum NIZO
B253, Lactobacillus casei NIZO B255, and Lactobacillus reuteri
ASM20016 showed that L. reuteri and L. casei, in contrast to L.
plantarum, prime DCs to promote the development of Treg cells.
Experiments with TLR transfectants showed that none of the three
lactobacilli tested substantially activated TLRs. However, L. reuteri
and L. casei both potently induce the development of Treg cells and
are recognized by DC-SIGN on DCs, an interaction that appears to
be crucial for the priming of regulatory DCs (36). Another study
showed that the direct interaction between DCs and Lactobacil-
lus acidophilus NCFM is sufficient to induce IL-10 production
and low IL-12p70 production by these cells. This acquisition of
a non-inflammatory phenotype by the DCs was dependent on
the activation of DC-SIGN that recognizes surface layer protein
A (SlpA) of the bacterium. L. acidophilus with mutated SlpA fails
to induce Th2 polarization of the DCs, and instead, promotes
IL-12p70, TNF-α, and IL-1 production (37). Additionally, it was
reported that transfer of LAB-treated bone-marrow-derived DCs
protects mice from 2-4-6-trinitrobenzenesulfonic acid-induced
colitis. This effect is mediated by TLR2 and NOD2 activation of
the DCs and depends on the activation of Treg cells (38). Teichoic
acid, a cell wall component of the Gram-positive bacteria L. plan-
tarum NCIMB8826, is involved in the anti-inflammatory activity
of this strain. A mutant with enhanced anti-inflammatory capacity
incorporates much lower levels of d-Ala in its teichoic acids than
the wild-type strain and induces dramatically reduced secretion
of pro-inflammatory cytokines by blood monocytes, resulting in
a significant increase in IL-10 production. The effects observed
were clearly TLR2 dependent. This mutant was also more pro-
tective in a murine colitis model than its wild-type counterpart
(39). Some probiotics activate anti-inflammatory and regulatory
immune effects in the settings of enteric infections and mucosal
inflammation. Lactobacillus paracasei CNCM I-4034 and its super-
natant dramatically reduce the production of IL-6, IL-8, IL-12p70,
and TNF-α in human intestinal DCs challenged with Salmonella
typhi (40). These authors demonstrated that L. paracasei CNCM
I-4034 activates the expression of TLR2 in DCs, up-regulates the
expression of TOLLIP, and promotes the stimulation of TGF-β2,
whereas the supernatant of the probiotic increases the secretion of
TGF-β1.
Lebeer et al. (41) suggested that the final outcome of a host
cell response against probiotic bacteria depends on the combi-
nation of the distinct MAMPs that can interact with the vari-
ous PRRs and associated co-receptors that fine-tune signaling;
as well as on the concentration of these MAMPs. To date, sev-
eral MAMPs of immunobiotics have been indentified, that can be
connected to specific host responses (41) and these effector mol-
ecules are in many cases associated with the bacterial cell surface
(42). Although most beneficial effects of probiotics require direct
bacterium-cell contact with live bacteria, some reports demon-
strated that soluble factors secreted by probiotics are able to mod-
ulate the production of cytokines and therefore, to modulate the
immune system. In fact, recent investigations have exposed some
of the underlying mechanisms in the modulation of gut immune
system by probiotic soluble factors. Peña and Versalovic (43)
reported that L. rhamnosus GG specifically inhibits TNF-α pro-
duction and reduces TNF-α/IL-10 ratios in a murine macrophage
model with an anti-inflammatory net effect. This effect is contact-
independent, requiring the presence of a soluble L. rhamnosus GG
immunomodulin for complete modulatory activity. The putative
immunomodulin has a protein or peptide component that inhibits
TNF-αproduction in murine macrophages. Further research work
using L. rhamnosus GG strain, to investigate molecular mech-
anisms by which probiotics regulate IECs, reported the purifi-
cation of two novel L. rhamnosus GG-derived soluble proteins,
p75 and p40. Each of these purified protein preparations acti-
vated Akt, inhibited cytokine-induced epithelial cell apoptosis, and
promoted cell growth in human and mouse colon epithelial cells
and cultured mouse colon explants. TNF-induced colon epithelial
damage was significantly reduced by p75 and p40. Immunodeple-
tion of p75 and p40 reversed the L. rhamnosus GG conditioned
media activation of Akt and its inhibitory effects on cytokine-
induced apoptosis and loss of IECs (44). These findings suggest
that probiotic bacterial components may be useful for preventing
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cytokine-mediated gastrointestinal diseases. Another example of
a secreted protein associated with probiotic activity is the prt-P-
encoded protease of L. paracasei that degrades secreted CXCL10
(also called IP-10), resulting in reduced lymphocyte recruitment
in an ileitis model (45). Secreted factors produced by Lactobacillus
casei-rhamnosus were tested on human lymphocytes, monocytes,
and a human monocytic leukemia-cell line (THP-1). The soluble
factor(s) present in supernatants effectively induced apoptosis of
immune cells. These were mainly soluble heat-stable proteins. For
immune cells, pre-treatment with the supernatant significantly
promoted apoptosis via a mitochondrial pathway. The super-
natant also inhibited the release of LPS-induced pro-inflammatory
cytokines TNF-α, IL-1β, IL-6, and IL-8 by immune cells (46). It
was also described that in the human gut, L. plantarum secretes
an extracellular protein that releases an internal fragment (STp)
when is cleaved by intestinal proteases. It is characterized by the
abundance of serine and threonine residues within its sequence.
STp is encoded in one of the main extracellular proteins pro-
duced by such species, which includes some probiotic strains.
In vitro studies using DCs from human peripheral blood showed
that STp increased the production of regulatory IL-10 in healthy
controls. In addition, T cells stimulated with STp-pulsed DCs
decreased the production of pro-inflammatory IFNs and increased
anti-inflammatory IL-10 production, suggesting that these T cells
acquired an immunoregulatory phenotype (47).
INTESTINAL INFLAMMATION IN PIGLETS AFTER WEANING:
IMPACT OF PROBIOTICS IN IMMUNE HEALTH AND
PRODUCTIVITY
The weaning transition is a complex period during which the
piglets have to face an abrupt separation from their mother, mixing
with other litters in a usually new environment, and switch from
milk to a solid feed which involves a change from a highly digestible
to a less-digestible and more-complex feed. In consequence, sev-
eral physiological changes occur in the intestine of pigs during the
process of weaning [reviewed in Ref. (11)]. Early studies of Pluske
et al. (48) showed that weaning induces several modifications in
the intestinal tissue including changes in villus and crypt archi-
tecture and reduced activities of brush-border digestive enzymes.
Moreover, these histological and physiological modifications have
been implicated in a higher susceptibility to intestinal pathogens
such as E. coli and rotaviruses (48). Changes in the gut microbiota
have been also described. The gut of piglets is sterile at birth and is
then colonized by microbes from the mother and the environment,
starting with lactic acid bacteria, enterobacteria, and streptococci.
After weaning and the introduction of solid feed obligate anaer-
obes increase in number and diversity until an adult-type pattern is
achieved (11, 49). These modifications in microbial communities
has a great impact in the gastrointestinal health of piglets, con-
sidering that microbial activity is important for improvement of
energy yield, vitamin production, fermentation of carbohydrates,
gut motility, production of volatile fatty acids, and water and Na+
absorption [reviewed in Ref. (11)].
In addition, it has to be considered that the piglet is not
immunocompetent at birth. Piglet is dependent on a supply of
several specific and non-specific immune factors present in mater-
nal colostrum and milk for immune protection, resistance against
pathogens, development, and survival. Clearly, development of
immunocompetence is an absolute requirement for optimum
growth and performance. Early weaning at 3 weeks of age is asso-
ciated with a transient reduction in the ability of intraepithelial
lymphocytes to respond to mitogens and splenic T cells to secrete
IL-2. Furthermore, tolerance to fed proteins introduced at weaning
is not fully achieved until 8 weeks of age (11).
A growing body of experimental and clinical evidence sup-
ports the therapeutic and preventive application of probiotics for
several gastrointestinal inflammatory disorders in pigs. In this
regard, Qiao et al. (50) conducted experiments to evaluate the
effects of a complex Lactobacilli preparation on performance,
resistance to E. coli infection and gut microbial flora of weaning
pigs. The mix of four lactobacilli (Lactobacillus gasseri, L. reuteri,
L. acidophilus, and Lactobacillus fermentum) isolated from wean-
ing pigs was able to reduce E. coli and anaerobe counts in the
gut, and decrease diarrhea. Additionally, lactobacilli treatment sig-
nificantly improved average daily feed intake of pigs compared
to controls during the first 2 weeks after weaning and the aver-
age daily gain (50). It is known that the ratio of Bacteroidetes
and Firmicutes bacterial groups in the gut can affect the abil-
ity to absorb nutrients. Therefore, Cui et al. (51) investigated the
effect of probiotic Bacillus subtilis on Bacteroidetes and Firmi-
cutes in cecal contents and growth performance and fat deposition
in weaning piglets. The study found that the addition of B. sub-
tilis improves growth performance and affects lipid metabolism
through regulation of the proportion of Bacteroidetes and Fir-
micutes in the gut. Herfel et al. (52) examined the impact of a
novel probiotic strain of Bifidobacterium longum AH1206 on the
health, growth, and development of neonatal pigs. Authors found
that ileal IL-10 expression increased progressively with AH1206
supplementation, which indicated the potential for modulation
of the inflammatory tone of the intestinal mucosa of suckling
piglets. However, no differences were found between AH1206-
treated and control piglets when comparing body weight gain, feed
efficiency (gain:intake), and histological and physiological mod-
ifications in intestines. Another recent study evaluated the effect
of the co-administration of B. subtilis RJGP16 and Lactobacil-
lus salivarius B1 on intestinal immunity in piglets (53). Authors
demonstrated that probiotic administration increased the expres-
sion of IL-6, porcine beta-defensins, and IgA producing cells in the
intestine, clearly showing that co-administration of RJGP16 and
B1 strains strongly enhances the intestinal mucosal immunity of
piglets.
Some recent studies have specifically evaluated the capacity of
probiotics to improve the resistance of piglets against ETEC. It was
shown that the probiotic strain L. plantarum CJLP243 may serve
as a potential alternative to antibiotic supplementation to improve
the growth and health performance of weaning pigs because of
its capacity to reduce the severity of ETEC-induced diarrhea
(54). Li et al. (55) showed that pre-treatment of piglets with L.
rhamnosus ATCC7469 ameliorates F4+ETEC-induced diarrhea.
In piglets exposed to F4+ETEC, jejunal TLR4 and IL-8 expres-
sion were increased; however, these increases were attenuated by
administration of L. rhamnosus. Notably, expression of jejunal
TLR2, ileal TLR9, NOD1, and TNF-α was up-regulated in the
ATCC7469-treated piglets after F4+ETEC challenge (55). These
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results indicate that probiotic treatments would be able to ben-
eficially modulate the overwhelming inflammatory response in
infected piglets.
Although these studies demonstrated that is possible to mod-
ulate piglets’ gut microbiota and immunity and improve growth
performance by using appropriate probiotics strains, the true effi-
cacy of probiotics in agricultural animals remains unclear because
of inconsistent experimental results. Explanations for the dispar-
ities between studies include differences in experimental condi-
tions, animal age, genetics, and health status. Additionally, the
inconsistent results could be attributed to a lack of understanding
of detailed cellular and molecular mechanism of action, as well
as unknown interactions among these bacteria, the host, and the
intestinal microbiota (56).
MODULATION OF TLR4-MEDIATED INFLAMMATION IN
INTESTINAL EPITHELIAL CELLS BY LACTOBACILLUS
JENSENII TL2937
Intestinal epithelial cells are a central component of the immune
system of the gut. Several works have demonstrated that micro-
bial recognition by IECs is an integral aspect of first-line host
responses. Then, current observations point to the idea that more
than simply a physical barrier separating luminal contents from
mucosal APCs, the intestinal epithelium is increasingly recognized
as playing an essential role in immune homeostasis, through the
promotion of tolerogenic and regulatory responses. These find-
ings have important implications for the regulation of mucosal
homeostasis by probiotic bacteria. To study the mechanisms by
which IECs induce an immune response to pathogens and the
potential immunoregulatory effect of immunobiotics in pigs, we
established a clonal porcine intestinal epitheliocyte cell line (PIE
cells) (58). Studies of TLRs expression in PIE cells demonstrated
that TLR4 is expressed most strongly. It was confirmed that PIE
cells, which preferentially express TLR4/MD-2, undergo inflam-
matory responses regarding cytokine expression in response to
LPS stimulation (58). Moreover, stimulation of PIE cells with
porcine-specific ETEC significantly increases the levels of IL-6,
IL-8, and monocyte chemotactic protein (MCP)-1 (57). It was
also found that damage to PIE cells correlates with the levels
of pro-inflammatory cytokines produced after stimulation with
ETEC and LPS (57), which is consistent with reports demon-
strating that challenging human intestinal Caco-2 cells with ETEC
causes strong up-regulation of pro-inflammatory mediators that
lead to membrane damage (59, 60). We selected lactobacilli strains
that regulate the inflammatory response induced by ETEC and
LPS in PIE cells by evaluating the levels of IL-1α, IL-6, IL-8, and
MCP-1. The challenge of PIE cells with the intestinal pathogen
significantly increased levels of pro-inflammatory cytokines in
lactobacilli-untreated control cells (61). However, IL-6 and IL-8
levels in PIE cells stimulated with some lactobacilli strains, espe-
cially L. jensenii TL2937, were significantly lower than those in
the control (61). Interestingly, L. jensenii TL2937, a strain with
a high capacity to activate TLR2, was also the strain with the
highest capacity to down-regulate IL-6 and IL-8 production by
PIE cells in response to ETEC and LPS. For this reason, we
became interested in L. jensenii TL2937 and examined the mecha-
nisms behind the anti-inflammatory effect mediated by this strain,
and demonstrated that L. jensenii TL2937 inhibits NF-κB and
MAPK signaling pathways in ETEC- and LPS-challenged PIE cells
(Figure 2).
Proteins that regulate the intensity and duration of TLR activa-
tion are able to modulate the cellular outcome, thereby controlling
whether TLR activation leads to homeostatic or inflammatory
responses (14). To dissect the mechanism(s) involved in the anti-
inflammatory effect of L. jensenii TL2937, the effect of this strain
on the expression of the negative TLR regulators in PIE cells was
evaluated. The expression of SIGIRR, Tollip, A20, Bcl-3, MKP-1,
and IRAK-M was studied, and it was found that MKP-1, A20, and
Bcl-3 mRNA expression was up-regulated in PIE cells stimulated
with L. jensenii TL2937 (61) (Figure 2). MKP-1 plays a role in the
inhibition of pro-inflammatory mRNA expression by inactivating
MAPK. MKP-1 desensitizes cells to TLR ligands by inactivating
the p38 signaling pathway in enterocytes (62). Moreover, MKP-1
is not induced by TLR2 stimulation, although ligands for TLR3,
TLR4, TLR5, and TLR9 induce MKP-1. This is in agreement with
our finding that the TLR2 ligand Pam3CSK4 itself does not induce
the expression of MKP-1 (61). Bcl-3 functions as an inhibitor of
NF-κB activity by stabilizing repressive NF-κB homodimers in a
DNA-bound state and preventing the binding of transcriptionally
active dimers. In fact, stabilization of repressive complexes through
the induction of Bcl-3 expression has been proposed to function
during the processes of LPS tolerance (63). Moreover, treatment of
macrophages with IL-10 induces the expression of Bcl-3, leading
to inhibition of LPS-induced TNF-α production (64).
Lactobacillus jensenii TL2937 also upregulate the expression
of A20 in PIE cells. A20 is a zinc finger protein that inhibits
activation of NF-kB via inflammatory cytokine receptors (65,
66), TLR (67, 68), and the nucleotide-binding oligomerization
domain-containing receptor NOD2 (69). A20 functions via its
two ubiquitin-editing activities, an N-terminal deubiquitinase that
removes K63-linked polyubiquitin chains and a C-terminal ubiq-
uitin ligase that facilitates target protein degradation via attach-
ment of K48-linked poly-ubiquitin chains (66, 70). These two
activities cooperatively down-regulate TRAF6 (71). Therefore,A20
plays an essential role in the termination of NF-kB signaling in
response to TNF-α and microbial products such as LPS (72). A20
deficiency in enterocytes renders mice sensitive to TNF-a-induced
lethal inflammation, leading to disruption of the epithelial bar-
rier and infiltration of commensal bacteria that initiate a systemic
inflammatory response (73). These data suggest that A20 is impor-
tant for the inhibition of innate immune responses in the gut
(26). In addition, gut decontamination with a mixture of antibi-
otics with limited oral bioavailability in drinking water markedly
reduces A20 protein and mRNA levels in the ileal epithelium of
mice (74). Moreover, partial rather than complete abrogation of
A20 expression is likely due to incomplete elimination of intestinal
bacteria by the antibiotic treatment (74). These results show that
A20 expression in the epithelium positively correlates with the bac-
terial load in the lumen. The observations that A20-deficient mice
develop severe gut inflammation early in life (75) and that this
inflammatory state can be alleviated by antibiotics or knockout of
the TLR signaling mediator myeloid differentiation factor MyD88
(76) further support a key role for A20 in intestinal tolerance to
the intestinal microbiota.
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FIGURE 2 | Modulation of negative regulators of toll-like receptor-4 signaling pathway by Lactobacillus jensenii TL2937 in porcine intestinal epithelial
cells and antigen presenting cells.
Recently, it was demonstrated that B. longum BB536 and Bifi-
dobacterium breve M-16V significantly down-regulated levels of
IL-8, MCP-1, and IL-6 in PIE cells challenged with ETEC by mod-
ulating the NF-kB and MAPK pathways (77). Moreover, both bifi-
dobacteria up-regulated A20 in PIE cells. Then, the most effective
anti-inflammatory strains evaluated in our laboratory, L. jensenii
TL2937 and bifidobacteria strains BB536 and M-16V, strongly
up-regulated the ubiquitin-editing enzyme A20. This finding is
of interest because it not only shows a common mechanism for
the anti-inflammatory activity of immunobiotics but also pro-
vides a potential biomarker for the screening and selection of new
immunoregulatory strains.
MODULATION OF TLR4-MEDIATED INFLAMMATION IN
INTESTINAL ANTIGEN PRESENTING CELLS BY
LACTOBACILLUS JENSENII TL2937
Considering the anti-inflammatory effects of the TL2937 strain
in IECs and the critical importance of APC polarization in
immunoregulation, it was also examined the effect of L. jensenii
TL2937 on activation patterns of APCs from porcine Peyer’s
patches (PPs). In swine, the most frequent marker expressed
on DCs and macrophages is CD172a. Additionally, CD11R1
is considered to be a marker that is specifically and differen-
tially expressed on porcine DCs, but not on macrophages (78).
Then, in our studies we used CD172a and CD11R1, together
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with MHC-II, to define three different populations of APCs
in porcine PPs: CD172a+CD11R1high, CD172a−CD11R1low, and
CD172a+CD11R1− cells (79). According to our studies and pre-
viously published works (72, 80, 81), CD172a+CD11R1high and
CD172a−CD11R1low cells could be DCs, and CD172a+CD11R1−
cells could be macrophages; however, functional studies are needed
to accurately define each population. Therefore, in our studies, we
refer to each of the three populations as APCs.
Ex vivo experiments using the adherent population of PPs
APCs showed that the treatment with L. jensenii TL2937 increases
the expression of IL-10 and TGF-β in CD172a+CD11R1high and
CD172a+CD11R1− cells, whereas treatment with this bacterium is
associated with increased levels of IFN-γ in CD172a−CD11R1low
cells (79). Then, the direct exposure of porcine APCs to L. jensenii
TL2937 in the absence of inflammatory signals activates CD172a+
APCs and causes them to become phenotypically and functionally
mature and to display tolerogenic properties (79). Our findings
show similarities to previous studies with lactobacilli and APCs
from different species. For example, human myeloid DCs exposed
to lactobacilli show increased expression of MHC-II and co-
stimulatory molecules (39, 82, 83). Moreover, similar to our work,
previous studies by Drakes et al. (36) reveal that probiotic lacto-
bacilli induce up-regulation of IL-10 production and cell surface
markers of maturation and activation in DCs (36).
On the contrary, L. jensenii TL2937 increased the produc-
tion of IFN-γ in CD172a−CD11R1low cells (79). One pos-
sible explanation for the differential immunoregulatory effect
of TL2937 may be the levels of expression of TLR2 in
distinct APCs. CD172a+CD11R1high, CD172a+CD11R1−, and
CD172a−CD11R1low cells differ regarding TLR2 expression (79),
and therefore, they are likely to differ in the degree to which they
interact with L. jensenii. In support of this hypothesis, it was
reported that teichoic acid, a cell wall component of the Gram-
positive bacteria L. plantarum NCIMB8826, is involved in the
anti-inflammatory activity of this strain. A mutant with enhanced
anti-inflammatory capacity incorporates much lower levels of d-
Ala in its teichoic acids than the wild-type strain and induces
dramatically reduced secretion of pro-inflammatory cytokines by
blood monocytes, resulting in a significant increase in IL-10 pro-
duction. The effects observed were clearly TLR2 dependent. This
mutant was also more protective in a murine colitis model than its
wild-type counterpart (37). Other PRRs would be also involved in
the immunoregulatory effect of immunobiotics on APCs. Com-
parative studies using L. plantarum NIZO B253, L. casei NIZO
B255, and L. reuteri ASM20016 showed that L. reuteri and L. casei,
in contrast to L. plantarum, prime DCs to promote the develop-
ment of Treg cells. Experiments with TLR transfectants showed
that none of the three lactobacilli tested substantially activated
TLRs. However, L. reuteri and L. casei both potently induce the
development of Treg cells and are recognized by DC-SIGN on DCs,
an interaction that appears to be crucial for the priming of regu-
latory DCs (84). Another study showed that the direct interaction
between DCs and L. acidophilus NCFM is sufficient to induce IL-
10 production and low IL-12p70 production by these cells. This
acquisition of a non-inflammatory phenotype by the DCs was
dependent on the activation of DC-SIGN that recognizes SlpA of
the bacterium (85).
Treatment of APCs with L. jensenii TL2937 also results in
differential modulation of the production of pro- and anti-
inflammatory cytokines in response to ETEC or LPS challenges.
The differential effects of the TL2937 strain in each PPs APC pop-
ulation persist because increased production of IFN-γ is observed
in CD172a−CD11R1low cells and improved synthesis of IL-
10 is detected in CD172a+CD11R1high and CD172a+CD11R1−
cells (79).
In order to find the mechanism(s) involved in the immunoreg-
ulatory effects of the TL2937 strain, the expression of negative
regulators of TLRs in porcine APCs was also evaluated. Of the six
regulators tested, SIGIRR, A20, and IRAK-M mRNA expression
was up-regulated in CD172a+ cells stimulated with L. jensenii
TL2937 (Figure 2). It was shown in vitro that overexpression of
SIGIRR inhibits TLR-induced NF-κB activation and attenuates
the production of inflammatory cytokines (86). The LPS-induced
inflammatory response is enhanced in SIGIRR-deficient mice (87).
As described above, A20 also has an essential role in regulating
inflammatory responses in the gut (68, 72). Notably, IRAK-M-
deficient cells stimulated with TLR ligands or bacteria produce an
increase in NF-κB and MAPK activation and elevated amounts
of pro-inflammatory cytokines, such as IL-12, IL-6, and TNF-
α (88). IRAK-M expression is induced upon LPS stimulation,
and endotoxin tolerance is diminished in IRAK-M-deficient cells;
these observations indicate that IRAK-M plays a critical role in
regulating innate immunity through a negative feedback loop
(89). Therefore, induction of these three negative regulators by
L. jensenii TL2937 in CD172a+ APCs cells from swine PPs may be
important for establishing tolerance to LPS and ETEC (Figure 2).
Although our studies in PIE cells and APCs demonstrated the
ability of immunobiotics to modulate the inflammatory response,
these in vitro models may be overly simplified and may not
account for the effect of cell-cell interactions in a complex organic
microenvironment, completely changing the resulting response.
As mentioned before, IECs express a broad range of factors that
may influence intestinal APCs and lymphocytes (90, 92). There-
fore, to further assess the immunoregulatory effect of L. jensenii
TL2937, in a recent study a co-culture system with a PIE cell mono-
layer and immunocompetent cells from swine PPs was used to
model an in vitro PP culture system (91).
A significant up-regulation of pro-inflammatory cytokines was
observed in PIE cells co-cultured with PPs APCs and challenged
with ETEC or LPS. These results were consistent with findings
described for PIE cells monocultures described above. Therefore,
PIE cells did not responded differently to TLR4 activation when
co-cultured with APCs (91). Moreover, it was confirmed that the
pre-treatment of PIE cells with L. jensenii TL2937 reduced pro-
inflammatory cytokines in response to ETEC or LPS and that this
effect was related to up-regulation of the three TLR negative reg-
ulators: A20, Bcl-3, and MKP-1 as in PIE cell monocultures (61,
91, 93). In addition, L. jensenii TL2937-treated PIE cells were able
to significantly upregulate TGF-β expression (91). It is well known
that IECs-derived factors are able to condition mucosal DCs to
secrete cytokines such as IL-10 and TGF-β in response to commen-
sal microbes, thereby initiating differentiation of Treg immune
responses (94). Moreover, conditioning of monocyte-derived DCs
with IECs supernatants confer on DCs the capacity to produce
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large amounts of IL-10, which is attributable, at least in part, to
the release of the IECs-derived factors such as TGF-β and thymic
stromal-derived lymphopoietin (TSLP) (95). Therefore, in addi-
tion to its direct tolerogenic effects on PIE cells, L. jensenii TL2937
could have an indirect anti-inflammatory effect on APCs under
the influence of factors produced by PIE cells such as TGF-β (91).
The study of the indirect effect of L. jensenii TL2937 on APCs
in co-cultures, demonstrated that the response of these cells was
completely different to those observed in APCs monocultures. In
PIE-APCs co-cultures, no modifications in the levels of TGF-β
in CD172a+CD11R1− and CD172a+CD11R1high cells or levels
of IFN-γ in CD172a−CD11R1low cells were observed. However,
increased levels of IL-10 were found in CD172a+ cells co-cultured
with PIE cells (91). In addition, no modification in SIGIRR, A20
or IRAK-M expression was observed in those cells. Notably, Bcl-3
expression was up-regulated in APCs cells co-cultured with PIE
cells (91) (Figure 2). The Bcl-3 protein functions as an inhibitor
of NF-κB activity. It was reported that treatment of macrophages
with IL-10 induces the expression of Bcl-3, and Bcl-3 expression
leads to inhibition of LPS-induced TNF-α production (64). Then
it is probable that immunoregulatory cytokines (IL-10) produced
by APCs act in an autocrine way and upregulate the expression
Bcl-3. Then, the response of PPs APCs to L. jensenii TL2937 is
significantly modified when the stimulus is mediated indirectly
through IECs (91).
IMPACT OF LACTOBACILLUS JENSENII TL2937 IN PIGS’
IMMUNE HEALTH AND PRODUCTIVITY
Recent in vivo data concerning the immunoregulatory effect of
L. jensenii TL2937 demonstrated that the administration of this
immunobiotic strain improved immune health and growing per-
formance and productivity of piglets (91). Feeding the TL2937
strain to 3 week-old LWD piglets significantly increased carcass
grading (according to the standards of the Japanese Meat Grad-
ing Association) and improved juicy, tenderness, and overall
palatability.
As mentioned before, at weaning, piglets are stressed, the food
intake is strongly depressed, the structure and function of the
gastrointestinal tract are altered, and these conditions can favor
bacterial translocation, inflammation, and infection with patho-
genic bacteria. It was reported that the optimal gut microbiota
significantly improves intestinal health and beneficially affects the
efficiency of gastrointestinal and whole body growth through-
out the productive life cycle of a pig (11). In this regard, studies
on the expression profiles induced by gut microbiota in the ileal
epithelium of neonatal piglets showed and enhanced expression
of NF-κBIA, a protein associated with the inactivation of NF-
κB by sequestration, and the negative regulator of TLRs TOLLIP
together with the down-regulation of GATA1 in colonized ver-
sus germ-free animals; reflecting the activation of pathways that
prevent excessive inflammation. In addition, it is extremely impor-
tant to direct piglets intestinal immune system toward appropriate
immune responses that strives to maintain intestinal homeostasis,
not only in the induction of tolerance against harmful antigens,
but in effective effectors responses against pathogens. Some stud-
ies have associated probiotic bacteria with the improvement of
intestinal homeostasis in pigs, albeit with different levels of success
as described previously (53, 55). Considering the capacity of L.
jensenii TL2937 to functionally modulate the response of PIE
cells and porcine APCs, it was hypothesized that this strain would
significantly impact on piglets’ immune heath. The in vivo exper-
iments in pigs indicate that L. jensenii TL2937 is able to improve
immunity and regulate excessive inflammation (91). These effects
seem to be related to the complex secretion of cytokines induced
by the probiotic strain in the gut. L. jensenii TL2937 could strongly
induced secretion of IL-10 and IFN-γ that would be related to the
beneficial effects achieved by the immunobiotic strain (91). The
capacity to modulate inflammation and improve defenses at the
same time has been described for several probiotic strains (95, 96).
L. jensenii TL2937 could be included in the list of probiotic strains
with those capabilities.
CONCLUSION
Post-weaning diarrhea mainly occurs within the first week after
weaning and affects pigs across the globe, causing great economic
loss to the swine industry due to reduced growth performance and
considerable morbidity and mortality. Our studies demonstrated
that the use of immunobiotics strains as supplemental additives
for piglet feedings could be used as a strategy to maintain and
improve intestinal homeostasis; that is important for the develop-
ment of the pig and for health and performance throughout the
productive life of the animal.
The scientific research into probiotic mode of actions has come
to age and has shown how probiotics are able to induce beneficial
changes in the host. Our research work allows us to propose a
complete view of the cellular and molecular mechanisms involved
in the immunoregulatory effects of L. jensenii TL2937 (Figure 3).
When reaching the porcine intestinal mucosa, L. jensenii TL2937
would have the capacity to interact with local cells at three lev-
els (Figure 3): (i) the interaction of the TL2937 strain with IECs
would induce the up-regulation of MKP-1, Bcl-3, and A20 expres-
sion, which would be mostly dependent on TLR2 activation as we
have demonstrated for several immunobiotic bacteria including
the TL2937 strain; (ii) L. jensenii TL2937 could be taken by APCs
indirectly through M cell transport or by direct sampling from the
intestinal lumen, inducing an increase in the production of the
immunoregulatory cytokines IL-10 and TGF-β by CD172a+ cells
as well as the expression of SIGIRR, IRAK-M, and A20. In addition,
through its direct interaction with CD172a−CD11R1low cells, the
TL2937 strain would have the capacity to improve Th1 responses
by increasing the production of IFN-γ and; (iii) L. jensenii TL2937,
through its capacity of stimulating the production of immunoreg-
ulatory factors such as TGF-β in EICs, would indirectly increase
the expression of Bcl-3 and the production of IL-10 in CD172a+
APCs reinforcing its effects in these cells. Then, L. jensenii TL2937
would functionally modulated IECs and APCs to improve resis-
tance against infections and avoid unproductive inflammation. In
fact, experiments using ETEC challenge, clearly demonstrated that
the TL2937 strain is able to induce protection against inflamma-
tory damage and improve immunity at the same time (Figure 3). It
was also demonstrated that the immunological networks induced
by L. jensenii TL2937 help to maintain intestinal tolerance and
improve the development of appropriate protective and controlled
immune responses. Then, L. jensenii TL2937 has a great potential
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FIGURE 3 | Proposed mechanism for the immunoregulatory effect of
Lactobacillus jensenii TL2937 in porcine intestinal mucosa.
to be used as a pig probiotic feed. In addition, accumulation of
empirical data in pigs may increase the probiotic use in human
because the pigs are also expected for development as human
model.
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